CAS: 202821-81-6 - 3-(5-chloro-2-hydroxybenzyl)-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2(3H)-one

Fórmula: C₁₆H₁₀ClF₃N₂O₃

InChI: InChI=1/C16H10ClF3N2O3/c17-12-5-6-13(23)10(7-12)8-22-15(24)25-14(21-22)9-1-3-11(4-2-9)16(18,19)20/h1-7,23H,8H2

Sinónimos:

• 1,3,4-Oxadiazol-2(3H)-one, 3-[(5-chloro-2-hydroxyphenyl)methyl]-5-[4-(trifluoromethyl)phenyl]-
• 3-((5-chloro-2-hydroxyphenyl)methyl)-5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2(3H)-one

1,3,4-Oxadiazol-2(3H)-one, 3-[(5-chloro-2-hydroxyphenyl)methyl]-5-[4-(trifluoromethyl)phenyl]-

CAS: 202821-81-6

• Fórmula: C₁₆H₁₀ClF₃N₂O₃
• Pureza: %
• Cor e Forma: Solid
• Peso molecular: 370.7104

BMS-191011

CAS: 202821-81-6

BMS-191011 (BMS-A) is an activator of large-conductance calcium-activated potassium (BKCa) channels ,effective in stroke models

• Fórmula: C₁₆H₁₀ClF₃N₂O₃
• Pureza: 98%
• Cor e Forma: Solid
• Peso molecular: 370.71

3-(5-Chloro-2-Hydroxybenzyl)-5-[4-(Trifluoromethyl)Phenyl]-1,3,4-Oxadiazol-2(3H)-One

CAS: 202821-81-6

3-(5-Chloro-2-Hydroxybenzyl)-5-[4-(Trifluoromethyl)Phenyl]-1,3,4-Oxadiazol-2(3H)-One is a water soluble drug that inhibits the transfer of proteins from one cell …

• Fórmula: C₁₆H₁₀ClF₃N₂O₃
• Pureza: Min. 95%
• Peso molecular: 370.71 g/mol